What is Nanobiotix?
{{Infobox company | name = Nanobiotix | traded_as = {{Euronext|NANO|FR0011341205|XPAR}}<br>CAC Small | foundation = 2003 | location_city = Paris, France | key_people = [[Laurent Levy]]<br><small>( [[Chief executive officer|CEO]])</small> | industry = [[Biotechnology]] | products = NBTXR3 (Hensify®) | operating_income = €2.54 million (2019) | assets = €54.9 million (2019) | num_employees = 110 <small>(2020)</small> | homepage = [http://nanobiotix.com/ www.nanobiotix.com] }} '''Nanobiotix''' is a [[biotechnology]] company. It uses nanomedicine to develop new radiotherapy techniques for cancer patients. The [[Home Office|home office]] of the company is in [[Paris]]. Also, it has offices in [[New York]] and [[Massachusetts]]. Nanobiotix is a spin-off of the [[State University of New York]] (SUNY) at Buffalo. {{tech-stub}} [[Category:Biotechnology companies]] [[Category:Technology companies of France]] [[Category:Companies based in Paris]]